Talaris awarded 2020 Citeline Award for Clinical Trial Result of the Year

On September 17, 2020, Talaris was awarded the 2020 Citeline Award for Clinical Trial Result of the Year.  This award recognizes the clinical trial which reported results that had the greatest impact and is expected to lead to an advance in healthcare. The judges sought to recognize the clinical trial with the largest commercial impact, highest impact on patient population, the greatest disruption in a market, or the advancement of clinical trial design.

The 2020 Citeline Awards (previously CARE Awards) were created to recognize myriad accomplishments across the biopharmaceutical industry, providing an opportunity for the industry to honor its highest achievers. Achievements across the spectrum of key R&D activities are celebrated, from successes in early and late-stage research, to advances in technological tools, to innovations in trial design and execution.

The Citeline Awards gather distinguished leaders in the biopharmaceutical, CRO, and diagnostic industries from all corners of the globe.  To learn more, visit:

https://pharmaintelligence.informa.com/events/awards/citeline-awards-2020